← All trials
NCT04827537
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2021
- Primary completion
- Dec 31, 2027
- Completion date
- Dec 31, 2027
- First posted
- Apr 1, 2021
- Last posted
- Apr 14, 2022
- Enrollment
- 200
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Research Institute of Epidemiology, Microbiology and Infectious Diseases, UzbekistanLead sponsor
- Research Institute of Epidemiology, Microbiology and Infectious Diseases, UzbekistanReponsible party - principal investigator
- Research Institute of Epidemiology, Microbiology and Infectious Diseases, UzbekistanSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.